Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer earlier. This tool may help guide treatment, such as signalling when to ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...